C07K 5/00
Peptides containing up to four amino acids in a fully defined sequence
Official title: Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
C07K5/00 (Peptides containing up to four amino acids in a fully defined sequence) appears on 7,930 US grants and 6,761 published applications in this corpus.
Search patents in C07K- Granted patents
- 7,930
- Published applications
- 6,761
- Assignees
- 2,991
- Inventors
- 16,987
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 44 | 0 |
| 1977 | 47 | 0 |
| 1978 | 61 | 0 |
| 1979 | 41 | 0 |
| 1980 | 61 | 0 |
| 1981 | 72 | 0 |
| 1982 | 60 | 0 |
| 1983 | 55 | 0 |
| 1984 | 99 | 0 |
| 1985 | 101 | 0 |
| 1986 | 105 | 0 |
| 1987 | 150 | 0 |
| 1988 | 133 | 0 |
| 1989 | 146 | 0 |
| 1990 | 110 | 0 |
| 1991 | 118 | 0 |
| 1992 | 138 | 0 |
| 1993 | 135 | 0 |
| 1994 | 121 | 0 |
| 1995 | 166 | 0 |
| 1996 | 213 | 0 |
| 1997 | 276 | 0 |
| 1998 | 313 | 0 |
| 1999 | 245 | 0 |
| 2000 | 241 | 0 |
| 2001 | 221 | 38 |
| 2002 | 220 | 226 |
| 2003 | 211 | 326 |
| 2004 | 166 | 293 |
| 2005 | 149 | 310 |
| 2006 | 199 | 269 |
| 2007 | 166 | 254 |
| 2008 | 150 | 231 |
| 2009 | 169 | 304 |
| 2010 | 192 | 302 |
| 2011 | 170 | 281 |
| 2012 | 186 | 269 |
| 2013 | 229 | 304 |
| 2014 | 242 | 317 |
| 2015 | 242 | 315 |
| 2016 | 269 | 304 |
| 2017 | 204 | 262 |
| 2018 | 187 | 290 |
| 2019 | 183 | 258 |
| 2020 | 178 | 251 |
| 2021 | 163 | 262 |
| 2022 | 126 | 210 |
| 2023 | 126 | 241 |
| 2024 | 136 | 259 |
| 2025 | 120 | 225 |
| 2026 | 75 | 160 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Polypeptide compound and use thereof in treatment of enteritis29 Sep 2026US 12,747,267 B2Sichuan Gooddoctor Panxi Pharmaceutical Co., Ltd.
- Aqueous peptide programming of the vinylidene fluoride ferroelectric phase29 Sep 2026US 12,747,302 B2Northwestern University
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Modulators of programmed death-ligand-122 Sep 2026US 12,741,965 B2Southern Research Institute
- Small molecule LIN28 inhibitors as anticancer agents22 Sep 2026US 12,741,987 B2Arumugavadivel Narendran
- Amino acid-derived ceramide, synthesis method therefor and use thereof1 Oct 2026US 2026/0297018 A1Shenzhen Dikeman Biotechnology Co., Ltd.
- Reversible surfactant and multifunctional drug delivery systems based thereon1 Oct 2026US 2026/0297127 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Universal abt compounds and uses thereof24 Sep 2026US 2026/0284204 A1Kleo Pharmaceuticals, Inc.
- Synthesized biologically active compounds and methods of making and using24 Sep 2026US 2026/0285903 A1Georgia State University Research Foundation, Inc.
- Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives17 Sep 2026US 2026/0273017 A1Ambrx, Inc.
Most cited
By later US patents
- Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support822US 5,288,514 AThe Regents of the University of California · 1994
- Peptide nucleic acids763US 5,539,082 A1996
- Lysosomal enzyme-cleavable antitumor drug conjugates653US 6,214,345 B1Bristol-Myers Squibb Company · 2001
- Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility543US 5,714,331 A1998
- Peptide nucleic acids having amino acid side chains515US 5,719,262 A1998